A simplified pathway to proprotein convertase subtilisin/kexin type 9 inhibitor prior authorization approval: A lipid clinic experience

Authors

Anum Saeed, Baylor College of Medicine, Houston, TX, USA
Salim S. Virani, Baylor College of Medicine, Houston, TX, USAFollow
Peter H. Jones, Baylor College of Medicine, Houston, TX, USA
Vijay Nambi, Michael E. DeBakey VA Medical Center, Houston, US
Danièle Zoch, Baylor College of Medicine, Houston, TX, USA
Christie Mitchell Ballantyne, Baylor College of Medicine, Houston, USA

Document Type

Editorial

Department

Cardiology

Comments

Abstract is not provided by the author/publisher. This work was published before the author joined Aga Khan University.

Publication (Name of Journal)

Journal of Clinical Lipidology

Recommended Citation

Saeed, A., Virani, S. S., Jones, P. H., Nambi, V., Zoch, D., Ballantyne, C. M. (2017). A simplified pathway to proprotein convertase subtilisin/kexin type 9 inhibitor prior authorization approval: A lipid clinic experience. Journal of Clinical Lipidology, 11(3), 596-599.
Available at: https://ecommons.aku.edu/provost_office/373